ROBINTECH
  • RobinVac
  • Tests and data
  • PRESS
  • CONTACT
  • About RobinTech
Picture

About
RobinTech

About RobinTech

RobinVac in brief
RobinTech is a Danish company that develops health care products with substantial global impact. RobinVac is a COVID-19 vaccine extractor that enables vaccinators to pull seven doses of the COVID-19 vaccine out of a multi dose vial instead of, as now, only six doses. RobinVac works as a digital vaccine extractor that combined with a specific method, extracts the vaccines from the vial. RobinVac thus enables vaccinators to increase the number of COVID-19 vaccines from a single vial, by one dose, or from six doses to seven doses of COVID-19 vaccines. 
The story of Robin as the denominator for all our products and new developments is referring to Robin Hood and to our aim to make our products accessible for all, regardless of economic characteristics.
Our vision
RobinTech is a strong supporter of United Nations Global Sustainable Goals (SDG). In particular we are inspired by ‘Good health and well-being’. Thus, our approach is always that our products and new developments must support our vision to 'Ensure healthy lives and promote well-being for all at all ages'.
The RobinTech team
Picture
CEO & Founder
André Larsen
B. Sc. Mechanical Engineering

Picture
Medical Director & Partner
Martin Vesterby

MD, Ph.D.
Picture
Partner
Bettina Elbæk Pedersen

Ms. Sc. Mechanical Engineering
Picture
CFO & Partner
Claus Rehfeld
M. Sc., Econ. - MBA, Global Business
Picture
Partner
Svend Egenfeldt

Ms. Sc. Mechanical Engineering
Picture
COO
​Anne Sofie Bukkehave Engedal

M. Sc. African studies & Anthropology

333 million

 extra doses of Pfizer-BioNTech vaccines can be extracted with RobinVac in 2021
Send us your message
Submit
Powered by Create your own unique website with customizable templates.
  • RobinVac
  • Tests and data
  • PRESS
  • CONTACT
  • About RobinTech